EP3651725A1 - Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles - Google Patents

Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles

Info

Publication number
EP3651725A1
EP3651725A1 EP18740127.8A EP18740127A EP3651725A1 EP 3651725 A1 EP3651725 A1 EP 3651725A1 EP 18740127 A EP18740127 A EP 18740127A EP 3651725 A1 EP3651725 A1 EP 3651725A1
Authority
EP
European Patent Office
Prior art keywords
preparation
bis
inci
triazine
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18740127.8A
Other languages
German (de)
English (en)
Inventor
Kathrin Reske
Shimoda Toshihiko
Janina ZIPPEL
Andreas Bleckmann
Doreen Gutzke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP3651725A1 publication Critical patent/EP3651725A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/624—Coated by macromolecular compounds

Definitions

  • the present invention relates to a cosmetic preparation containing 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine ( INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) encapsulated with cellulose acetate and methods and uses of 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4 -methoxyphenyl) - 1, 3,5-triazine (INCI: bis-Ethylhexyloxyphenol methoxyphenyl triazines), which with
  • Cellulose acetate is encapsulated.
  • UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous
  • UVA and UVB filters are in the form of positive lists in most industrialized countries such as Appendix 7 of the
  • Cosmetic preparations such as sunscreen preparations applied to the skin, regularly (intentionally or unintentionally) come into contact with garments and items of laundry (eg towels) on which they are (eg, "attrition” or “sucked” by the fibers). to adhere in part. In this way, depending on the nature of the ingredients, especially on bright textiles stains and discoloration.
  • the object is surprisingly achieved by a cosmetic preparation containing 2,4-bis ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3,5- triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) which is encapsulated with cellulose acetate.
  • a cosmetic preparation containing 2,4-bis ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3,5- triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) which is encapsulated with cellulose acetate.
  • the object is further achieved by a process for facilitating the leachability of 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3 , 5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) containing cosmetic preparations of textiles, characterized in that the cosmetic preparation, the 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] - phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) in cellulose acetate-encapsulated form.
  • NCI bis-ethylhexyloxyphenol methoxyphenyl triazines
  • the object is not least solved by the use of 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3,5- triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine), which is encapsulated with cellulose acetate, in cosmetic preparations to facilitate the washability of this UV protection filter from textiles contaminated with the preparations.
  • INCI bis-ethylhexyloxyphenol methoxyphenyl triazine
  • the cellulose acetate-encapsulated 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3,5-triazine can be prepared, inter alia, analogous Example 2 of WO2017 / 037716, wherein bis-Ethylhexyloxyphenol methoxyphenyl triazines instead of titanium dioxide and
  • Bismuthoxychlorides is used. Likewise, it can be prepared analogously to Example 2 of WO2014 / 133261 using instead of the PMMA cellulose acetate and instead of 4- (tert-butyl) -4'-methoxydibenzoylmethane the bis-ethylhexyloxyphenol methoxyphenyl triazines.
  • the product can be obtained from Tagra Biotechnologies LTD, Netanya.
  • the preparation according to the invention comprises one or more further UV filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane, hexyl 2- [4- (diethylamino) -2- hydroxybenzoyl] benzoate (INCI: diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole-5-sulfonic acid salt, 2,4,6-tris [anilino (p-carbo-2'-ethyl-1 '-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), 4,4 '- [[6 - [[4 - [[(1, 1-dimethylethyl) amino] carbonyl] phenyl] amino] -1, 3,5-triazine 2,4-diyl] diimino] bis, bis
  • UV filters can advantageously be used in individual concentrations of 0.1 to 10% by weight, based on the total weight of the preparation.
  • the preparation of the invention is free of 2-hydroxy-4-methoxybenzophenone, 4-methoxycinnamic acid (2-ethylhexyl) ester 4-Methoxycinnt yarn- reisoamylester and / or 3- (4-methylbenzylidene) camphor.
  • Particular preference should be given to the use of 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isoamyl ester 3- (4-methylbenzylidene) camphor and 2-hydroxy-4-methoxybenzophenone.
  • the preparation according to the invention is furthermore free of 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI:
  • Ethylhexyloxyphenol methoxyphenyl triazines which is encapsulated with cellulose acetate, in an amount of 0, 1 to 15% by weight, preferably in an amount of 0.5 to 10% by weight and particularly preferably in an amount of 1 to 7% by weight , in each case based on the total weight of the preparation contains.
  • the weight ratio of cellulose acetate to bis-ethylhexyloxyphenol methoxyphenyl triazines in the capsules according to the invention is advantageously 20:80 to 60:40 and
  • Emulsion is present.
  • the preparation is in the form of an oil-in-water emulsion (O / W emulsion).
  • O / W emulsion is preferably in the form of a lotion.
  • the preparation according to the invention is in the form of an emulsion
  • Glyceryl stearate citrate cetearyl alcohol, sodium cetearyl sulfate, glyceryl stearate, cetearylsulfosuccinate, sodium stearoylglutamate, polyglyceryl-3-methylglucose distearate, stearic acid, potassium cetyl phosphate, polyglyceryl-10 stearate (INCI polyglyceryl-10 stearates) and / or polyclyceryl-2 caprate.
  • ingredients are advantageously used in individual concentrations of 0, 1 to 7% by weight, based on the total weight of the preparation.
  • the preparation according to the invention is free of polyethylene glycol, polyethylene glycol ethers and polyethylene glycol esters (so-called PEG derivatives).
  • Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises ethylhexylglycerol, propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1 Contains 2-decanediol.
  • the use concentration according to the invention (individual concentration) is for these ingredients from 0.01 to 5% by weight, based on the total weight of the preparation.
  • ethylhexylglycerol is particularly advantageous.
  • the advantageous use concentration according to the invention for ethylhexylglycerol is from 0.1 to 1% by weight, based on the total weight of the preparation.
  • the preparation according to the invention contains phenoxyethanol, 4-hydroxyacetophenone and / or ethanol.
  • Phenoxyethanol can be used according to the invention advantageously in a concentration of 0, 1 to 0.9% by weight, based on the total weight of the preparation.
  • 4-hydroxyacetophenone may advantageously be used in a concentration of up to 0.4% by weight, based on the total weight of the preparation.
  • ethanol can advantageously be used in a concentration of up to 10% by weight, based on the total weight of the preparation.
  • Preferred according to the invention is the use of a combination of phenoxyethanol and
  • the preparation of the invention selected one or more of the perfume substances from the list of compounds limonene, citral, linalool, alpha-lsomethylionon, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert -Pentylcyclohexylacetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C, butylphenylmethyl-propionalcinnamal, Amyl salicylate, amyl cinnamyl alcohol, aniseed alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil
  • Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises one or more oils selected from the group of the compounds butylenes glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropylsebacate, Dicaprylylcarbonate, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate,
  • Triheptanoin C12-13 alkyl lactates, C16-17 alkyl benzoates, propylheptyl caprylates,
  • Caprylic / capric triglycerides diethylhexyl 2,6-naphthalates, octyldodecanol, caprylic / capric triglycerides, ethylhexyl cocoate.
  • Total weight of the preparation can be used.
  • Embodiments of the present invention which are advantageous according to the invention are also characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, glycyrrhetinic acid, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, ⁇ -alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.
  • the preparation comprises one or more compounds selected from the group of the compounds al
  • Embodiments of the present invention that are advantageous according to the invention are further characterized in that the preparation contains acrylate / C 10-30 alkyl acrylate crosspolymer and / or tricontanyl PVP.
  • Not least advantageous according to the invention is when the preparation according to the invention contains xanthan gum, tapioca starch and / or carboxymethyl cellulose.
  • the preparation according to the invention comprises silica dimethyl silylates and / or talcum.
  • the preparation of the invention may advantageously contain humectants.
  • Humectants are substances or mixtures of substances which give cosmetic preparations the property, after application or distribution on the skin surface, the moisture release of the horny layer (also transepidermal water loss (TEWL)) and / or to positively influence the hydration of the horny layer.
  • the aqueous phase of the preparations according to the invention may advantageously comprise conventional cosmetic auxiliaries, such as, for example, alcohols of low C number, preferably ethanol and / or isopropanol or polyols of low C number and their ethers, electrolytes, self-tanning agents and in particular one or more thickeners or which can be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, for.
  • conventional cosmetic auxiliaries such as, for example, alcohols of low C number, preferably ethanol and / or isopropanol or polyols of low C number and their ethers, electrolytes, self-tanning agents and in particular one or more thickeners or which can be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, for.
  • hyaluronic acid As hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose and / or polyacrylates (preferably a polyacrylate from the group of so-called carbopols, for example, Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination).
  • carbopols for example, Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination.
  • the leachability of the sunscreen from textiles can be determined, for example, by the following method:
  • Cotton textiles were examined over an in vitro application / wash cycle.
  • White prewashed cotton monitors (100% cotton) are used.
  • 3 mg / cm 2 of the test formulation were distributed evenly on PMMA Schönberg plates (5.0 ⁇ 5.0 cm) and transferred directly to the test textile by means of pressure. Subsequently, the stained cotton samples are air-dried for 12 hours under laboratory conditions.
  • a colorimetric characterization of the resulting initial staining is carried out by measuring the degree of yellowing with the colorimeter DATACOLOR 800 (Datacolor International).
  • Type of light / observer D65 / 10 ° (corresponding to average daylight)
  • UV filtering adapted to D65, Ganz / Griesser method
  • Sample background Base paper without optical brightener, test climate: 21 ° C ( ⁇ 1 ° C), 41% ( ⁇ 4%) rel. Humidity.
  • the B-axis characterizes the color impression yellow / blue in the CIE-Lab system, whereby positive b-values represent an increase in the yellow component. The higher the b value, the greater the yellow impression.
  • Test cloth in a washing machine 60 ° C, 2h, Ariel Compact powder detergent, clean load.
  • a colorimetric is again carried out Characterization of the resulting stain by measuring the color values as already described with the colorimeter DATACOLOR 800 (Datacolor International).
  • the CIE-Lab System or L * a * b * Color Space is a three-dimensional measurement space containing all perceptible colors. The color space is based on the
  • Brightness axis L is perpendicular to this plane. According to DIN 6174, L, a and b must be written with * in order to distinguish themselves from others, eg the "Hunter-Lab" system.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une préparation cosmétique contenant de la 2,4-bis-{[4- (2-éthyl-hexyloxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine (INCI : Bis-éthylhexyloxyphénol méthoxyphényl triazine), qui est encapsulée avec de l'acétate de cellulose, ainsi que des procédés et des utilisations de la 2,4-bis-{[4-(2-éthyl-hexyloxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine (INCI : Bis-éthylhexyloxyphénol méthoxyphényl triazine) encapsulée avec de l'acétate de cellulose.
EP18740127.8A 2017-07-13 2018-06-29 Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles Withdrawn EP3651725A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017212017.7A DE102017212017A1 (de) 2017-07-13 2017-07-13 Sonnenschutzmittel mit Schutz vor Textilverfleckung durch 2,4-Bis-{[4-(2-ethyl-hexyl-oxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin
PCT/EP2018/067604 WO2019011670A1 (fr) 2017-07-13 2018-06-29 Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles

Publications (1)

Publication Number Publication Date
EP3651725A1 true EP3651725A1 (fr) 2020-05-20

Family

ID=62904420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18740127.8A Withdrawn EP3651725A1 (fr) 2017-07-13 2018-06-29 Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles

Country Status (4)

Country Link
US (1) US20200163856A1 (fr)
EP (1) EP3651725A1 (fr)
DE (1) DE102017212017A1 (fr)
WO (1) WO2019011670A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022122133A1 (fr) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprenant des filtres uv et un ou plusieurs (bio)-alcanediols

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090155371A1 (en) * 2007-12-17 2009-06-18 Sojka Milan F Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same
US10322301B2 (en) * 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
KR101509556B1 (ko) 2013-02-26 2015-04-07 주식회사 경동나비엔 급배기 열교환기를 구비한 연소장치
US20160008237A1 (en) * 2013-02-28 2016-01-14 Tagra Biotechnologies Ltd. Microcapsules comprising sunscreen agents
DE102014206152A1 (de) 2014-04-01 2015-10-01 Beiersdorf Ag Sonnenschutzmittel mit verkapselten UV-Filtern I
DE102014206147A1 (de) 2014-04-01 2015-10-01 Beiersdorf Ag Sonnenschutzmittel mit verkapselten UV-Filtern II
DE102014206156A1 (de) 2014-04-01 2015-10-01 Beiersdorf Ag Sonnenschutzmittel mit verkapselten UV-Filtern III
DE102014015554A1 (de) * 2014-10-22 2016-04-28 Beiersdorf Ag Polysaccharid-haltige Sonnenschutzmittel mit reduzierter Neigung zur Textilverfleckung
EP3344220B1 (fr) 2015-09-03 2024-05-08 Tagra Biotechnologies Ltd Microcapsules encapsulant un agent réfléchissant

Also Published As

Publication number Publication date
WO2019011670A1 (fr) 2019-01-17
US20200163856A1 (en) 2020-05-28
DE102017212017A1 (de) 2019-01-17

Similar Documents

Publication Publication Date Title
EP3351236B1 (fr) Préparation anti-solaire sans octocylène à base de stéarate de polyglycéryle-10
EP3335691B1 (fr) Préparation anti-solaire contenant des polysaccharides présentant une tendance réduite à tâcher les tissus
EP3354253B1 (fr) Utilisation de diéthylamino hydroxybenzoyl hexyl benzoate dans les produits anti-solaire cosmétiques
EP3311791B1 (fr) Inhibiteur de lumière éthanolique présentant une tendance réduite à tâcher les tissus
EP3761944B1 (fr) Agent de protection solaire ayant une tendance réduite à former des taches sur les textiles et contenant de l'huile végétale hydrogénée et une combinaison de filtre uv composée d'éthylhexyl triazone et de 4-(tert.-butyl)-4'-méthoxydibenzoylméthane
EP3378537B1 (fr) Agent photoprotecteur contenant du triacontanyl pvp
DE102015218065A1 (de) Glycerin-haltiges Kosmetikum mit Vinylpyrrolidon/Triaconten-Copolymer
EP3651725A1 (fr) Produit de protection solaire avec protection contre l'apparition de taches dues à la 2,4-bis-{[4-(2-éthyl-hexyl-oxy)-2-hydroxy]-phényl}-6-(4-méthoxyphényl)-1,3,5-triazine sur les textiles
EP3761948B1 (fr) Agent de protection solaire ayant une tendance réduite à former des taches sur les textiles et contenant de l'huile végétale hydrogénée et des diéthylamino hydroxybenzoyl hexyl benzoates
EP3378465B1 (fr) Agent photoprotecteur contenant du polyglycéryle-10 stéarate et polyglycéryle-2 caprate
EP3723707A1 (fr) Produit de protection solaire à tendance réduite à former des taches sur les textiles
WO2019011671A1 (fr) Produit de protection solaire avec protection contre l'apparition de taches dues à l'hexyl 2-[4-(diéthylamino)-2-hydroxybenzoyl]benzoate sur les textiles
EP3761949B1 (fr) Agent de protection solaire ayant une tendance réduite à former des taches sur les textiles et contenant de l'huile végétale hydrogénée et des bis-éthylhexyloxyphénol méthoxyphényl triazines
EP3600564B1 (fr) Produit de protection solaire contenant du polyglycéryl-10-stéarate et du citronellol
EP3600565B1 (fr) Produit de protection solaire contenant du polyglycéryl-10-stéarate et du linalol
WO2019011669A1 (fr) Produit de protection solaire avec protection contre l'apparition de taches dues au 4-(tert-butyl)-4'-méthoxydibenzoylméthane sur les textiles

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200213

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20201222